A study of aspirin resistance in type 2 diabetes.
dc.contributor.author | Singla, Mani Kant | en_US |
dc.contributor.author | Lahiri, Prabir | en_US |
dc.contributor.author | Mukhopadhyay, Pradip | en_US |
dc.contributor.author | Pandit, Kaushik | en_US |
dc.contributor.author | Chaudhuri, Utpal | en_US |
dc.contributor.author | Chowdhury, Subhankar | en_US |
dc.date.accessioned | 2008-11-17 | en_US |
dc.date.accessioned | 2009-05-31T10:43:39Z | |
dc.date.available | 2008-11-17 | en_US |
dc.date.available | 2009-05-31T10:43:39Z | |
dc.date.issued | 2008-11-17 | en_US |
dc.description.abstract | Aspirin is currently known to give inadequate protection against coronary artery disease in diabetes compared to person without it. We evaluated 97 consecutive patients with type 2 diabetes for assessing laboratory aspirin resistance and attempted to assess the impact of various clinical and biochemical parameters on it. Thirty-eight patients (39.1%) were found to be less sensitive to the action of aspirin, 7 persons (7.2%) were found to be resistant and 31 persons (31.9%) were aspirin semi-responders. Only total cholesterol, LDL-cholesterol and triglyceride had statistically significant impact on aspirin resistance (p<0.05). Three persons out of 9 with some form of macrovascular disease had aspirin resistance. | en_US |
dc.description.affiliation | Department of Endocrinology, IPGME&R and SSKM Hospital, Kolkata. | en_US |
dc.identifier.citation | Singla MK, Lahiri P, Mukhopadhyay P, Pandit K, Chaudhuri U, Chowdhury S. A study of aspirin resistance in type 2 diabetes. Journal of the Indian Medical Association. 2008 Nov; 106(11): 720, 722-3, 740 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/99640 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.jimaonline.org.in/ | en_US |
dc.subject.mesh | Aspirin --administration & dosage | en_US |
dc.subject.mesh | Cholesterol, LDL --blood | en_US |
dc.subject.mesh | Coronary Artery Disease --blood | en_US |
dc.subject.mesh | Diabetes Mellitus, Type 2 --blood | en_US |
dc.subject.mesh | Diabetic Angiopathies --blood | en_US |
dc.subject.mesh | Drug Resistance | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Platelet Aggregation --drug effects | en_US |
dc.subject.mesh | Platelet Aggregation Inhibitors --administration & dosage | en_US |
dc.subject.mesh | Platelet Function Tests | en_US |
dc.subject.mesh | Risk Factors | en_US |
dc.subject.mesh | Triglycerides --blood | en_US |
dc.title | A study of aspirin resistance in type 2 diabetes. | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1